Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Twist Bioscience Corporation (TWST : NSDQ)
 
 • Company Description   
Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California.

Number of Employees: 652

 
 • Price / Volume Information   
Yesterday's Closing Price: $32.30 Daily Weekly Monthly
20 Day Moving Average: 1,268,975 shares
Shares Outstanding: 56.26 (millions)
Market Capitalization: $1,817.33 (millions)
Beta: 1.20
52 Week High: $139.99
52 Week Low: $25.88
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -20.68% -13.08%
12 Week -39.30% -34.13%
Year To Date -58.26% -50.37%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
681 GATEWAY BLVD.
-
SOUTH SAN FRANCISCO,CA 94080
USA
ph: 800-719-0671
fax: -
maeve@argotpartners.com http://www.twistbioscience.com
 
 • General Corporate Information   
Officers
Emily M. Leproust - Chief Executive Officer; President and Chair of th
James M. Thorburn - Chief Financial Officer
Kevin B. Yankton - Chief Accounting Officer
William Banyai - Director
Nicolas Barthelemy - Director

Peer Information
Twist Bioscience Corporation (CORR.)
Twist Bioscience Corporation (RSPI)
Twist Bioscience Corporation (CGXP)
Twist Bioscience Corporation (BGEN)
Twist Bioscience Corporation (GTBP)
Twist Bioscience Corporation (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 90184D100
SIC: 2836
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/05/22
Share - Related Items
Shares Outstanding: 56.26
Most Recent Split Date: (:1)
Beta: 1.20
Market Capitalization: $1,817.33 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.30 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-4.85 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.90
Price/Cash Flow: -
Price / Sales: 11.14
EPS Growth
vs. Year Ago Period: -58.97%
vs. Previous Quarter: -36.26%
Sales Growth
vs. Year Ago Period: 54.23%
vs. Previous Quarter: 14.54%
ROE
03/31/22 - -28.88
12/31/21 - -27.10
09/30/21 - -24.90
ROA
03/31/22 - -23.93
12/31/21 - -22.80
09/30/21 - -21.69
Current Ratio
03/31/22 - 7.85
12/31/21 - 4.81
09/30/21 - 8.67
Quick Ratio
03/31/22 - 7.32
12/31/21 - 4.31
09/30/21 - 8.16
Operating Margin
03/31/22 - -118.64
12/31/21 - -112.70
09/30/21 - -114.93
Net Margin
03/31/22 - -114.96
12/31/21 - -112.70
09/30/21 - -114.93
Pre-Tax Margin
03/31/22 - -122.68
12/31/21 - -121.17
09/30/21 - -116.39
Book Value
03/31/22 - 15.35
12/31/21 - 12.34
09/30/21 - 11.78
Inventory Turnover
03/31/22 - 2.91
12/31/21 - 3.28
09/30/21 - 3.92
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©